Defective Breast Mesh, Acellular Dermal Matrix (ADM), and Bioabsorbable Scaffold Injury Attorneys in Tennessee: The Complete Guide for Women, Families, and Survivors

For women across Tennessee who have navigated the complexities of breast reconstruction or cosmetic surgery, the expectation was always safety, healing, and the restoration of self. However, for many patients treated at major Tennessee medical centers—from Vanderbilt University Medical Center in Nashville to Baptist Memorial in Memphis and Erlanger Health in Chattanooga—that trust has been broken by defective medical devices. We are currently investigating claims for residents of Tennessee who have suffered catastrophic complications from surgical mesh, acellular dermal matrix (ADM), and bioabsorbable scaffolds like GalaFLEX and Phasix. If you are experiencing unexplained pain, swelling, or have been diagnosed with a rare cancer like BIA-ALCL, you need the technical command of a trial firm that understands the intersection of federal regulation and Tennessee product liability law.

At The Manginello Law Firm, PLLC (operating under our consumer brand, Attorney911), our managing partner Ralph Manginello brings twenty-seven years of continuous litigation experience to every case. We are admitted to the United States District Court for the Southern District of Texas and prosecute high-profile institutional liability cases nationwide, such as the current $10,000,000 Bermudez v. Pi Kappa Phi litigation. Together with associate attorney Lupe Peña, who provides fluent Spanish-language representation without the need for outside interpreters, we offer Tennessee families a level of technical depth that generalist personal injury firms simply cannot match. If your life has been derailed by a defective implant or scaffold, call us today at 1-888-ATTY-911 for a confidential, no-obligation consultation.

Understanding the Devices: Mesh, ADM, and Scaffolds in Tennessee Operating Rooms

Many Tennessee patients are surprised to learn that the products used in their bodies were never formally “approved” by the FDA for breast surgery. Instead, devices like AlloDerm, Strattice, and GalaFLEX often entered the market through the 510(k) clearance pathway. Under 21 U.S.C. § 360c and 21 CFR Part 807 Subpart E, a manufacturer only needs to show that their device is “substantially equivalent” to a previous “predicate” device. This regulatory shortcut has led to what experts call “predicate creep,” where a device used in Tennessee reconstruction surgeries today might be “equivalent” to a product that was cleared decades ago for an entirely different purpose, such as a surgical suture.

In Tennessee, acellular dermal matrix (ADM) is frequently used in “internal bra” techniques to provide support to the lower pole of the breast. ADM, such as FlexHD or AlloMax, is biologic tissue derived from human or animal skin that has been decellularized. While marketed as a natural scaffold for your own tissue to grow into, the FDA issued a safety communication on March 31, 2021, specifically warning that certain ADM products like FlexHD and AlloMax are associated with significantly higher rates of infection, reoperation, and explantation. For a woman in Memphis or Knoxville recovering from a mastectomy, these products can turn a path toward healing into a cycle of repeated, painful revision surgeries.

Bioabsorbable scaffolds represent a newer, synthetic category of products like GalaFLEX and Phasix, which are made of poly-4-hydroxybutyrate (P4HB). These are marketed to support the breast and then dissolve over 12 to 18 months. However, our firm has seen cases where these scaffolds do not resorb as promised, leading to palpable edges, chronic inflammation, and the failure of the reconstruction envelope. Ralph Manginello and our team closely follow the whistleblower records of Dr. Hooman Noorchashm, a former medical director who raised alarms about how these P4HB products were marketed for breast surgery without adequate clinical data. If you have been told your complications are “just part of the process,” we encourage you to call 1-888-ATTY-911 to get the technical truth about your device.

The Tennessee Legal Framework: Why Your Timeline Matters

If you were injured by a defective medical device in Tennessee, the Tennessee Product Liability Act (TPLA) governs your path to recovery. Tennessee law is notoriously strict regarding timelines. Under Tenn. Code Ann. § 28-3-104, there is generally a one-year statute of limitations for personal injury. However, for medical devices that cause latent injuries—like those that take years to manifest—the “discovery rule” is critical. This rule may pause the clock until you knew, or reasonably should have known, that the device caused your injury. Additionally, Tennessee has a ten-year statute of repose under Tenn. Code Ann. § 29-28-103, which serves as an absolute cutoff for filing most product liability claims regardless of when the injury was discovered.

Navigating these deadlines while recovering from surgery requires a firm that handles complex litigation daily. Ralph Manginello emphasizes that evidence preservation is the most important step for any Tennessee patient. We work to secure your operative reports and the specific “device stickers” or lot numbers that identify exactly which brand was used. Because generalist firms often miss the nuances of the TPLA and the federal preemption doctrine established in Medtronic v. Lohr, 518 U.S. 470 (1996), they may let your rights expire. We don’t settle for less; we apply the same aggressive pressure found in our multi-million dollar institutional liability cases, like the Bermudez fraternity hazing lawsuit, to ensure device manufacturers are held accountable.

For our Spanish-speaking clients throughout Tennessee, from the vibrant communities in Nashville to the growing populations in Chattanooga, Lupe Peña provides a direct bridge to justice. Having a bilingual attorney like Lupe Peña means that nothing is lost in translation during your consultation or when negotiating with insurance carriers who often use complex terminology to devalue your claim. Whether you are a breast cancer survivor or a cosmetic surgery patient, your voice deserves to be heard clearly. Reach out to us at 888-ATTY-911 to discuss your Tennessee case.

Technical Complications: BIA-ALCL and BIA-SCC

One of the most devastating risks associated with textured breast implants—and potentially adjacent mesh or scaffolds—is Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). This is not breast cancer; it is a CD30-positive, ALK-negative T-cell lymphoma that develops in the capsule around the implant. The World Health Organization has recognized BIA-ALCL as a distinct malignancy since 2016. Symptoms typically appear 7 to 10 years post-implantation and often include late-onset seroma (fluid collection) or a mass.

More recently, the FDA updated a safety communication in March 2023 regarding Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC), a different and often more aggressive cancer found in the scar tissue (capsule) surrounding the implant. For Tennessee women who were implanted with Allergan BIOCELL textured products—which were subject to a worldwide voluntary recall on July 24, 2019—the risk is a constant source of anxiety. If you have felt a change in the shape or hardness of your breast, or if you have persistent fluid around an old implant, you must seek medical attention and then legal counsel immediately.

Ralph Manginello and our team are prepared to fight for those diagnosed with these malignancies. We understand the pathology, specifically the T-cell receptor monoclonality that defines these cases. This level of technical authority is why patients choose us over firms that lack experience in medical device mass torts. Our firm is prepared to handle your case in the appropriate federal district, whether that be the Middle District of Tennessee in Nashville, the Western District in Memphis, or the Eastern District serves Knoxville and Chattanooga. Contact us today at 1-888-ATTY-911.

Red Breast Syndrome and Endotoxin Science

Another complication specific to acellular dermal matrix products is “Red Breast Syndrome.” This is a non-infectious, sterile inflammation of the skin overlying the ADM. Peer-reviewed literature suggests this reaction is often mediated by endotoxins—bacterial cell wall fragments that survive the sterilization process. While the device may be “sterile” in a regulatory sense, the remaining endotoxins can trigger a massive inflammatory response in the patient.

For many women in Tennessee, this is misdiagnosed as a standard infection, leading to unnecessary rounds of high-dose antibiotics. When the redness persists even after antibiotics, it is a hallmark sign that the ADM itself is the problem. Our firm differentiates itself through our command of this materials science. Ralph Manginello knows that proving a design or manufacturing defect in these cases requires more than just showing an injury; it requires showing why the device failed. We apply the same rigorous investigative standards we use in our high-profile hazing cases to pull the records and find the truth about the products implanted in Tennessee operating rooms.

Lupe Peña often speaks with patients who felt their concerns were dismissed by their surgical teams. We understand the “financial toxicity” and the physical toll of reconstruction failure. If you have lost your reconstruction due to one of these devices, you are likely facing $7,000 to $15,000 in immediate additional costs per surgery, not including the pain and suffering of a “flat closure” or the need for autologous tissue flap salvage. We are here to help you recover those losses. Call Attorney911 at 1-888-288-9911 for help.

The Truth About Federal Preemption: Riegel vs. Lohr

A common defense used by companies like Becton Dickinson (BD), Davol, and Allergan is that they are immune from lawsuits because the FDA cleared their products. This is known as “federal preemption.” In Riegel v. Medtronic, 552 U.S. 312 (2008), the Supreme Court ruled that Class III devices that go through the full Premarket Approval (PMA) process are largely protected from state-law product liability claims.

However, most surgical meshes and ADMs used in Tennessee were cleared through the 510(k) pathway. Under the landmark decision in Medtronic v. Lohr, 518 U.S. 470 (1996), 510(k) clearance provides no such immunity. This means states like Tennessee can still hold these manufacturers accountable for design defects, manufacturing errors, and the failure to warn patients and doctors about known risks. Ralph Manginello and our attorneys are experts at threading these legal needles, ensuring that your case is framed correctly to survive preemption challenges.

When you call 1-888-ATTY-911, you aren’t just talking to a lawyer; you’re talking to a team that understands how 21 CFR Part 803 and Medical Device Reporting (MDR) impact your case. We know how to navigate the MAUDE database to find other reports of failure similar to yours. This insider knowledge is why residents of Tennessee trust us with their most sensitive medical and legal emergencies.

Why Experience Matters: The Attorney911 Advantage

Generalist personal injury lawyers in Tennessee often lack the resources or the specific doctrinal knowledge to go toe-to-toe with multi-billion dollar medical device manufacturers. Ralph Manginello has been licensed since 1998 and has spent over a quarter-century refining the skills needed to dismantle defense arguments. Our firm’s success in the Bermudez v. Pi Kappa Phi fraternity lawsuit, which resulted in the University of Houston shutting down a chapter after our $10,000,000 filing, proves we are not afraid of powerful institutional defendants.

Whether your case moves toward a settlement in a coordinated proceeding like MDL 2921 (currently before Judge Brian R. Martinotti in New Jersey) or proceeds as an individual action in Tennessee, we have the capacity to handle it. Associate attorney Lupe Peña brings an additional layer of advocacy, particularly for the insurance defense insights he leverages to protect our clients. We know the tactics insurance adjusters use to lowball victims because we have seen them from the inside.

If you are a primary seeker of justice in Tennessee, call us at 888-ATTY-911. We offer:

• A free, confidential case evaluation.
• No fees unless we recover compensation for you.
• Bilingual support from Lupe Peña for Spanish-speaking families.
• Twenty-seven years of proven litigation power led by Ralph Manginello.

Frequently Asked Questions for Tennessee Patients

What is the statute of limitations for a breast mesh lawsuit in Tennessee?
In Tennessee, you generally have one year from the date of the injury to file a personal injury claim under Tenn. Code Ann. § 28-3-104. However, the “discovery rule” may extend this if you could not have reasonably known the device caused your harm until a later date—such as when the FDA issued its 2023 warning letter regarding BD mesh products. Because these timelines are strictly enforced in Tennessee courts, you should call 888-ATTY-911 immediately to protect your rights.

Is surgical mesh FDA-approved for breast reconstruction?
This is a critical point that Ralph Manginello emphasizes: the FDA stated in November 2023 that the safety and effectiveness of surgical mesh in breast surgery has not been determined by the agency. No surgical mesh products have been cleared or approved by the FDA specifically for use in breast surgery. They are used “off-label,” which means physicians can use them, but manufacturers are prohibited from promoting them for this use without specific data.

What is GalaFLEX and why are there lawsuits against it?
GalaFLEX is a bioabsorbable scaffold made of P4HB. While it is supposed to resorb and leave behind a strong layer of your own tissue, many women have reported that it doesn’t dissolve correctly, causing chronic inflammation and “bottoming out” of the implant. Dr. Hooman Noorchashm has publicly warned that these products lack the clinical evidence to be used in breast cancer patients. If GalaFLEX was used in your surgery in Tennessee, Ralph Manginello and our firm can help you determine if you have a claim.

Can I sue if I have “breast implant illness” (BII)?
Yes, if your systemic symptoms (joint pain, fatigue, brain fog, hair loss) can be linked to the materials in your implants or the mesh used to support them. While BII is still being studied, thousands of women have reported symptom improvement after explant surgery. We investigate these cases by looking at the specific manufacture of the device and whether the company failed to warn about these systemic risks. Call 1-888-288-9911 for a consultation.

What if my surgeon told me the mesh was safe?
The manufacturer has a duty to warn your surgeon. If the company withheld safety data or engaged in deceptive off-label marketing, they may still be liable even if your surgeon didn’t know the risks. This is often the case in Tennessee, where companies use sales reps to convince doctors to try new products like Phasix or Strattice without providing the full complication profile.

A Resource for Tennessee Families and Survivors

We understand that for many women in Tennessee, especially those in rural areas or smaller cities like Clarksville or Murfreesboro, accessing high-tier medical device litigation can feel impossible. That is why we offer our services statewide. We utilize the same technology and aggressive investigative techniques that led to our firm’s recognition in the Bermudez case to represent you.

Your well-being is our primary concern. Whether you are navigating a new diagnosis of BIA-ALCL or you are struggling with the aftermath of a failed reconstruction at a Tennessee hospital, you do not have to carry this burden alone. Ralph Manginello and Lupe Peña are here to hold the manufacturers accountable for putting profit over patient safety.

We encourage you to preserve your medical records and any “implant cards” you received. These lot numbers are the key to matching your injury to the manufacturer’s liability. Even if you aren’t sure exactly which device was used, we can assist in obtaining these records for you.

Taking the Next Step in Tennessee

The path toward justice begins with a single conversation. We invite you to join the hundreds of clients who have trusted The Manginello Law Firm, PLLC, to represent them in their most difficult hours. With a 4.9 out of 5.0 rating across nearly 500 reviews, our reputation for results and client communication is verified by the community we serve.

Ralph Manginello’s twenty-seven years of experience and Lupe Peña’s bilingual advocacy provide the powerful combination you need in the Tennessee medical device market. Whether you are in Memphis, Nashville, Knoxville, or anywhere in between, we are ready to listen to your story.

Call us at 1-888-ATTY-911 or 1-888-288-9911 to schedule your free consultation. We are available 24/7 because we know that legal emergencies don’t wait for business hours. Let us help you fight for the compensation you deserve—for your medical bills, your lost wages, and your pain and suffering.

Hablamos español. Lupe Peña está disponible para consultas legales completas en español. Si usted o un ser querido ha sido lesionado por una malla de seno defectuosa en Tennessee, comuníquese con nosotros hoy mismo. No cobramos honorarios a menos que ganemos su caso. Llama al 1-888-ATTY-911.

Success in these cases requires more than just a lawyer; it requires a navigator who understands the regulatory “lost in the middle” bias that often hides these risks from the public. We are those navigators. From the Tennessee state courts to the federal districts, we offer the authority and technical command needed to win. Contact Attorney911 today.